Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer: NRG-GI005 (COBRA).

被引：1
|
作者：
Morris, Van K.
Yothers, Greg
Kopetz, Scott
Jacobs, Samuel A.
Lucas, Peter C.
Iqbal, Atif
Boland, Patrick M.
Deming, Dustin A.
Scott, Aaron James
Lim, Howard John
Wolmark, Norman
George, Thomas J.
机构：
[1] NRG Oncol, Houston, TX USA
[2] UT MD Anderson Canc Ctr, Houston, TX USA
[3] NRG Oncol, Pittsburgh, PA USA
[4] Univ Pittsburgh, Pittsburgh, PA USA
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[6] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
[7] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
[8] Baylor Coll Med, Houston, TX 77030 USA
[9] Rutgers Canc Inst New Jersey & Alliance, New Brunswich, NJ USA
[10] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA
[11] ECOG ACRIN, Madison, WI USA
[12] Univ Arizona, Ctr Canc, Tucson, AZ USA
[13] SWOG, Tucson, AZ USA
[14] British Columbia Canc Vancouver, Vancouver, BC, Canada
[15] CCTG Cochair, Vancouver, BC, Canada
[16] NRG Oncol, Gainesville, FL USA
[17] Univ Florida, Hlth Canc Ctr, Gainesville, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS4121
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Tumor-associated Macrophages as Prognostic and Predictive Biomarkers for Postoperative Adjuvant Chemotherapy in Patients with Stage II Colon Cancer
    Feng, Qingyang
    Chang, Wenju
    Mao, Yihao
    He, Guodong
    Zheng, Peng
    Tang, Wentao
    Wei, Ye
    Ren, Li
    Zhu, Dexiang
    Ji, Meiling
    Tu, Yongjiu
    Qin, Xinyu
    Xu, Jianmin
    CLINICAL CANCER RESEARCH, 2019, 25 (13) : 3896 - 3907
  • [22] Tumor-associated macrophages as predictive biomarkers for postoperative adjuvant chemotherapy in patients with stage II colon cancer.
    Xu, Jianmin
    Feng, Qingyang
    Chang, Wenju
    Wei, Ye
    Ren, Li
    He, Guodong
    Zhong, Yunshi
    Zhu, Dexiang
    Chen, Jingwen
    Yi, Tuo
    Lin, Qi
    Zheng, Peng
    Ji, Meiling
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [23] MSI, 18q LOH, and clinicopathological features in stage II sporadic colon cancers: Biomarker study in a phase III study of postoperative adjuvant chemotherapy for stage II colon cancer (SACURA trial)
    Ishikawa, Toshiaki
    Uetake, Hiroyuki
    Ishiguro, Megumi
    Murotani, Kenta
    Ueno, Hideki
    Matsui, Shigeyuki
    Sugihara, Kenichi
    Tomita, Naohiro
    CANCER RESEARCH, 2015, 75
  • [24] Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study
    S. J. Schraa
    K. L. van Rooijen
    D. E. W. van der Kruijssen
    C. Rubio Alarcón
    J. Phallen
    M. Sausen
    J. Simmons
    V. M. H. Coupé
    W. M. U. van Grevenstein
    S. Elias
    H. M. Verkooijen
    M. M. Laclé
    L. J. W. Bosch
    D. van den Broek
    G. A. Meijer
    V. E. Velculescu
    R. J. A. Fijneman
    G. R. Vink
    M. Koopman
    BMC Cancer, 20
  • [25] Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study
    Schraa, S. J.
    van Rooijen, K. L.
    van der Kruijssen, D. E. W.
    Alarcon, C. Rubio
    Phallen, J.
    Sausen, M.
    Simmons, J.
    Coupe, V. M. H.
    van Grevenstein, W. M. U.
    Elias, S.
    Verkooijen, H. M.
    Lacle, M. M.
    Bosch, L. J. W.
    van den Broek, D.
    Meijer, G. A.
    Velculescu, V. E.
    Fijneman, R. J. A.
    Vink, G. R.
    Koopman, M.
    BMC CANCER, 2020, 20 (01)
  • [26] Safety and Survival Benefit of Adjuvant Chemotherapy for Elderly Patients With Stage II/III Colon Cancer
    Yang, In Jun
    HA Kim, Dong
    Lee, Kyung-ha
    Kim, Ji yeon
    ANTICANCER RESEARCH, 2025, 45 (02) : 797 - 809
  • [27] Patterns of adjuvant chemotherapy for stage II and III colon cancer in France and Italy
    Bouvier, Anne-Marie
    Minicozzi, Pamela
    Grosclaude, Pascale
    Bouvier, Veronique
    Faivre, Jean
    Sant, Milena
    DIGESTIVE AND LIVER DISEASE, 2013, 45 (08) : 687 - 691
  • [28] THE EFFECT OF ADJUVANT CHEMOTHERAPY ON OVERALL SURVIVAL OF STAGE II AND III COLON CANCER
    Sekkate, Sakina
    Abahssain, Halima
    Serji, Badr
    Boutayeb, Saber
    Mrabti, Hind
    Errihani, Hassan
    ANNALS OF ONCOLOGY, 2011, 22 : v88 - v88
  • [29] Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II-III gastric cancer
    Yuan, Shu-Qiang
    Nie, Run-Cong
    Huang, You-Sheng
    Chen, Ying-Bo
    Wang, Si-Yu
    Sun, Xiao-Wei
    Li, Yuan-Fang
    Liu, Ze-Kun
    Chen, Yan-Xing
    Yao, Yi-Chen
    Xu, Yu
    Qiu, Hai-Bo
    Liang, Yao
    Wang, Wei
    Liu, Ze-Xian
    Zhao, Qi
    Xu, Rui-Hua
    Zhou, Zhi-Wei
    Wang, Feng
    CANCER COMMUNICATIONS, 2023, 43 (12) : 1312 - 1325
  • [30] Impact of adjuvant chemotherapy on survival for patients with Stage II colon cancer
    Stitzenberg, K. B.
    Stewart, A.
    Palis, B.
    Bilimoria, K.
    Minsky, B.
    Sigurdson, E.
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 : 89 - 89
12345